Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2008-01-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.2007.081653PMID 18178690
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia.

  2010cited by this paper
• Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease.

  2007cited by this paper
• Cryoglobulinemia.

  2007cited by this paper
• BCL6 and outcome in diffuse large B-cell lymphoma: a work in progress

  2007cited by this paper
• Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?

  2007cited by this paper
• Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab.

  2006cited by this paper
• Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin's lymphoma patient.

  2006cited by this paper
• Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.

  2006cited by this paper
• Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.

  2006cited by this paper
• Treatment of hepatitis C virus-related systemic vasculitis.

  2005cited by this paper
• Serum sickness associated with rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia.

  2005cited by this paper
• PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.

  2005cited by this paper
• Rituximab Therapy for De Novo Mixed Cryoglobulinemia in Renal Transplant Patients

  2005cited by this paper
• Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.

  2004cited by this paper
• Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20.

  2003cited by this paper
• Anti-CD20 Therapy for Chronic Lymphocytic Leukemia-associated Autoimmune Diseases

  2003cited by this paper
• Efficacy and safety of rituximab in type II mixed cryoglobulinemia.

  2003cited by this paper
• Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis

  2003cited by this paper
• Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma.

  2000cited by this paper
• The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.

  1999cited by this paper
• World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

  1999cited by this paper
• Regression of monoclonal B‐cell expansion in patients affected by mixed cryoglobulinemia responsive to α‐interferon therapy

  1996cited by this paper
• Mixed cryoglobulinemia and hepatitis C virus.

  1994cited by this paper
• Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group.

  1994cited by this paper
• Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C

  1994cited by this paper
• [Mixed cryoglobulinemia and hepatitis C virus].

  1993cited by this paper
• Characterization of cryoglobulins by immunoblotting.

  1992cited by this paper
• A role for hepatitis C virus infection in type II cryoglobulinemia.

  1992cited by this paper
• Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases.

  1991cited by this paper
• Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients.

  1980cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• Biologic and clinical significance of cryoglobulins. A report of 86 cases.

  1974cited by this paper
• Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity.

  1966cited by this paper

• Meta-analysis of the efficacy of rituximab in the management of cryoglobulinemic vasculitis

  2025cites this paper
• Therapeutic Potential of Rituximab in Managing Hepatitis C-Associated Cryoglobulinemic Vasculitis: A Systematic Review

  2023influential citation
• Management of Hepatitis C Virus and Hepatitis B Virus Infection in the Setting of Kidney Disease.

  2023cites this paper
• Adult and childhood vasculitis.

  2023cites this paper
• Nonviral cryoglobulinemic vasculitis: an updated review for clinical practice

  2023cites this paper
• Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin

  2023cites this paper
• Efficacy of Direct Acting Antivirals and the Role of Corticosteroids in Rapidly Progressive Cryoglobulinemic Glomerulonephritis Associated to Hepatitis C Related Liver Cirrhosis

  2020cites this paper
• Glomerular Disease in Patients with Acute and Chronic Infections

  2020cites this paper
• Immunological Renal Diseases

  2019cites this paper
• PROSPECTS FOR ANTI-B-CELL THERAPY IN IMMUNO-INFLAMMATORY RHEUMATIC DISEASES

  2019cites this paper
• Treatment of Vasculitis of the Nervous System.

  2019cites this paper
• [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection].

  2018cites this paper
• [Renal involvement of cryoglobulinemia].

  2018cites this paper
• Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis

  2018cites this paper
• Cryoglobulinémies

  2018cites this paper
• Considering hepatitis C virus infection as a systemic disease

  2018cites this paper
• Autoimmune Kidney Diseases Associated with Chronic Viral Infections.

  2018cites this paper
• Clinical-evolutional particularities of the cryoglobulinemic vasculitis in the case of a patient diagnosed with hepatitis C virus in the predialitic phase

  2018cites this paper
• Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?

  2017cites this paper
• Manifestations hépatiques des maladies systémiques et des hémopathies

  2017cites this paper
• Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.

  2017cites this paper
• The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents

  2017cites this paper
• How I treat cryoglobulinemia.

  2017cites this paper
• Systematic review of the role of rituximab in treatment of antineutrophil cytoplasmic autoantibody-associated vasculitis, hepatitis C virus-related cryoglobulinemic vasculitis, Henoch–Schönlein purpura, ankylosing spondylitis, and Raynaud’s phenomenon

  2017cites this paper
• Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia

  2017cites this paper
• [Plasma exchange in nephrology: Indications and technique].

  2017cites this paper
• Kinetics of Rituximab Excretion into Urine and Peritoneal Fluid in Two Patients with Nephrotic Syndrome

  2017cites this paper
• Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis

  2017cites this paper
• Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection

  2017cites this paper
• Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection.

  2017cites this paper
• Chapter 38 – Other Vasculitis

  2016cites this paper
• Improved (4 Plus 2) Rituximab Protocol for Severe Cases of Mixed Cryoglobulinemia: A 6-Year Observational Study

  2016cites this paper
• Seminarios de la Fundación Española de Reumatología

  2016cites this paper
• Seminarios de la Fundación Española de Reumatología

  2016cites this paper
• Hepatitis C Therapy in Renal Patients: Who, How, When?

  2016cites this paper
• New insights into HCV-related rheumatologic disorders: A review

  2016cites this paper
• Extrahepatic manifestations of chronic hepatitis C virus infection

  2016cites this paper
• Biologic therapy in ANCA-negative vasculitis.

  2015cites this paper
• Extrahepatic manifestations in chronic hepatitis C virus carriers

  2015cites this paper
• Eular Textbook on Rheumatic Diseases

  2015cites this paper
• Vasculitic Neuropathies

  2015cites this paper
• Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral Agents-Based Antihepatitis C Virus Therapy

  2015cites this paper
• Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study.

  2015cites this paper
• [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].

  2015cites this paper
• [Treatment of cryoglobulinemic vasculitis associated with hepatitis C virus infection].

  2015cites this paper
• HCV Treatments and Their Integration Into Rheumatology

  2015cites this paper
• [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].

  2015cites this paper
• 110 – Rheumatologic aspects of viral infections

  2015cites this paper
• Treatment of cryoglobulinemic vasculitis associated with hepatitis C virus infection

  2015cites this paper
• Vasculitides and Hepatitis C Infection

  2015cites this paper
• Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature.

  2015cites this paper
• Essential mixed cryoglobulinemia manifesting as recurrent perioral edema: report of a case.

  2014cites this paper
• Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.

  2014cites this paper
• Atteinte rénale des cryoglobulinémies

  2014cites this paper
• Current and future therapeutic strategies for treating mixed cryoglobulinemia

  2014cites this paper
• Extrahepatic manifestations of chronic hepatitis C virus infection.

  2014cites this paper
• Reactivation of latent viruses after treatment with biological therapies

  2014cites this paper
• Membranoproliferative Glomerulonephritis, Type II Cryoglobulinemia and Triple Therapy for Hepatitis C: A Case Series and Review of the Literature

  2014cites this paper
• Documentation of off-label use of biologics in Rheumatoid Arthritis

  2013cites this paper
• Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases.

  2013cites this paper
• Mixed cryoglobulinemia: an unusual presentation of hepatitis C.

  2013cites this paper
• Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease.

  2013cites this paper
• Extrahepatic Manifestations of Hepatitis C Virus Infection

  2013cites this paper
• Renal involvement in HCV-related vasculitis.

  2013cites this paper
• Approccio innovativo al trattamento delle malattie glomerulari immuno-mediate

  2013cites this paper
• Cryoglobulinemic disease.

  2013cites this paper
• Biologicals

  2013cites this paper
• Échanges plasmatiques en néphrologie : techniques et indications

  2013cites this paper
• In Practice Hepatitis C Virus Infection , Mixed Cryoglobulinemia , and Kidney Disease

  2013cites this paper
• Cryoglobulinemia vasculitis: an update

  2013cites this paper
• L11. Hepatitis C virus mixed cryoglobulinemia vasculitis: therapeutic options.

  2013cites this paper
• Using Rituximab Plus Fludarabine and Cyclophosphamide as a Treatment for Refractory Mixed Cryoglobulinemia Associated With Lymphoma

  2013cites this paper
• Hepatitis C virus-induced vasculitis: therapeutic options

  2013cites this paper
• Antiviral Therapy for HCV-Associated Cryoglobulinemic Glomerulonephritis: Case Report and Review of the Literature

  2013cites this paper
• Drugs that act on the immune system: cytokines and monoclonal antibodies

  2012cites this paper
• Safety and efficacy of rituximab treatment for vasculitis in hepatitis B virus-associated type II cryoglobulinemia: a case report

  2012cites this paper
• [Current possibilities for treatment for hepatitis C virus-induced cryoglobulinemic vasculitis and B-cell lymphoma].

  2012cites this paper
• Hepatitis C Virus, Cryoglobulinemia, and Kidney: Novel Evidence

  2012cites this paper
• The vasculitic neuropathies: an update.

  2012cites this paper
• Successful treatment of IgM-monoclonal gammopathy of undetermined significance associated with cryoglobulinemia and cold agglutinin disease with immunochemotherapy with rituximab, fludarabine, and cyclophosphamide

  2012cites this paper
• Chapter 9: Infection-related glomerulonephritis

  2012cites this paper
• Management of Hepatitis C in Patients with Chronic Kidney Disease

  2012cites this paper
• HCV-Associated Membranoproliferative Glomerulonephritis

  2012cites this paper
• The Role of Rituximab in the Therapy of Mixed Cryoglobulinemia

  2012cites this paper
• Should HCV-Positive Asymptomatic Patients with Mixed Cryoglobulinemia Be Treated with Combined Antiviral Therapy?

  2012cites this paper
• Waldenström’s Macroglobulinemia Associated with Cryoglobulinemia: Pathogenetic, Clinical, and Therapeutic Aspects

  2012cites this paper
• Emergency in Cryoglobulinemia: Clinical and Therapeutic Approach

  2012cites this paper
• Rituximab in Cryoglobulinemic Vasculitis: First- or Second-Line Therapy?

  2012cites this paper
• Long-Term Course of Patients with Mixed Cryoglobulinemia

  2012cites this paper
• [Kidney involvement in mixed cryoglobulinemia: which treatment?].

  2012cites this paper
• KDIGO Clinical Practice Guideline for Glomerulonephritis

  2012cites this paper
• Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature

  2011cites this paper
• Treatment of Hepatitis C-Mediated Glomerular Disease

  2011cites this paper
• [Liver involvement in systemic diseases].

  2011cites this paper
• Recomendaciones de la Sociedad Española de Nefrología para el manejo de las alteraciones del metabolismo óseo-mineral en los pacientes con enfermedad renal crónica (S.E.N.-MM)

  2011cites this paper
• Consensus Statement of the Spanish Society of Rheumatology on Risk Management of Biologic Therapy in Rheumatic Patients

  2011cites this paper
• Drugs that act on the immune system

  2011cites this paper
• Clinical and epidemiological research

  2011cites this paper
• Secondary Glomerular Disease

  2011cites this paper
• Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.

  2011cites this paper